MADRID - Spanish researchers are trying to determine how to deal with an infestation of bacteria that is slowly eating the color out of one of the nation's most prized tourist sites - the Caves of Altamira.
The cave paintings of bison were discovered in 1868 in the northern Cantabria region. The red and black drawings have drawn international visitors into the caves for a peek into prehistoric times. However, with the visitors, numbering 3,000 daily in the 1970s, came body heat, moisture and breath.
Today, only 10 visitors are allowed per day to view the images because scientists fear bacteria brought in by tourists may be responsible for the fading of drawings' color. Samples taken from the images have produced Acidiobacterium - a very rare bacterium that scientists cannot grow successfully in laboratories. Little is know about the organism and researchers cannot determine why they are present within the caves. While they do not understand the Acidiobacterium's metabolism, the team has concluded the organism must thrive on iron, therefore reducing the images' pigment.
The solution is to introduce dim lighting that stimulates airborne algae - a bacterial food source, thereby reducing the amount of iron consumed.
The Spanish government has reportedly built exact replicas of the caves in a museum to further reduce the amount of visitors to the actual site.
Information from www.msnbc.com
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.